Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems

被引:67
作者
Su, Xiaomin [1 ]
Federoff, Howard J. [1 ,2 ]
机构
[1] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA
[2] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20057 USA
关键词
NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; DOPAMINE NEURON LOSS; GROWTH-FACTOR-ALPHA; NITRIC-OXIDE; CEREBROSPINAL-FLUID; MEDIATED NEUROTOXICITY; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE;
D O I
10.1155/2014/275178
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The etiology of Parkinson's disease (PD) is complex and most likely involves numerous environmental and heritable risk factors. Recent studies establish that central and peripheral inflammation occurs in the prodromal stage of the disease and sustains disease progression. Aging, heritable risk factors, or environmental exposures may contribute to the initiation of central or peripheral inflammation. One emerging hypothesis is that inflammation plays a critical role in PD neuropathology. Increasing evidence suggest that activation of the peripheral immune system exacerbates the discordant central inflammatory response and synergistically drives neurodegeneration. We provide an overview of current knowledge on the temporal profile of central and peripheral immune responses in PD and discuss the potential synergistic effects of the central and peripheral inflammation in disease development. The understanding of the nature of the chronic inflammation in disease progression and the possible risk factors that contribute to altered central and peripheral immune responses will offer mechanistic insights into PD etiology and pathology and benefit the development of effective tailored therapeutics for human PD.
引用
收藏
页数:9
相关论文
共 128 条
  • [1] Astrocyte-endothelial interactions at the blood-brain barrier
    Abbott, NJ
    Rönnbäck, L
    Hansson, E
    [J]. NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) : 41 - 53
  • [2] Arai H, 2006, HISTOL HISTOPATHOL, V21, P673, DOI 10.14670/HH-21.673
  • [3] Diabetes mellitus and progression of rigidity and gait disturbance in older persons
    Arvanitakis, Z
    Wilson, RS
    Schneider, JA
    Bienias, JL
    Evans, DA
    Bennett, DA
    [J]. NEUROLOGY, 2004, 63 (06) : 996 - 1001
  • [4] Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson's Disease?
    Barnum, Christopher J.
    Tansey, Malu G.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (04) : 350 - 358
  • [5] Adipose tissue, inflammation, and cardiovascular disease
    Berg, AH
    Scherer, PE
    [J]. CIRCULATION RESEARCH, 2005, 96 (09) : 939 - 949
  • [6] Causes of death in a community-based study of Parkinson's disease
    Beyer, MK
    Herlofson, K
    Årsland, D
    Larsen, JP
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (01): : 7 - 11
  • [7] Bjarnason IT, 2005, HELICOBACTER, V10, P557
  • [8] Who are we? Indigenous microbes and the ecology of human diseases
    Blaser, Martin J.
    [J]. EMBO REPORTS, 2006, 7 (10) : 956 - 960
  • [9] BLATTEIS CM, 1992, PROG BRAIN RES, V91, P409
  • [10] Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
    Block, Michelle L.
    Zecca, Luigi
    Hong, Jau-Shyong
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (01) : 57 - 69